AtriCure Cash on Hand 2006-2019 | ATRC

AtriCure cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
AtriCure Annual Cash on Hand
(Millions of US $)
2018 $124
2017 $34
2016 $44
2015 $35
2014 $60
2013 $26
2012 $12
2011 $14
2010 $13
2009 $16
2008 $11
2007 $20
2006 $19
2005 $34
AtriCure Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $80
Q2 2019 $91
Q1 2019 $101
Q4 2018 $124
Q3 2018 $40
Q2 2018 $37
Q1 2018 $36
Q4 2017 $34
Q3 2017 $34
Q2 2017 $35
Q1 2017 $34
Q4 2016 $44
Q3 2016 $41
Q2 2016 $42
Q1 2016 $23
Q4 2015 $35
Q3 2015 $48
Q2 2015 $54
Q1 2015 $56
Q4 2014 $60
Q3 2014 $59
Q2 2014 $63
Q1 2014 $79
Q4 2013 $26
Q3 2013 $30
Q2 2013 $35
Q1 2013 $36
Q4 2012 $12
Q3 2012 $13
Q2 2012 $13
Q1 2012 $15
Q4 2011 $14
Q3 2011 $15
Q2 2011 $16
Q1 2011 $16
Q4 2010 $13
Q3 2010 $11
Q2 2010 $12
Q1 2010 $12
Q4 2009 $16
Q3 2009 $15
Q2 2009 $16
Q1 2009 $9
Q4 2008 $11
Q3 2008 $12
Q2 2008 $12
Q1 2008 $15
Q4 2007 $20
Q3 2007 $21
Q2 2007 $29
Q1 2007 $16
Q4 2006 $19
Q3 2006 $20
Q2 2006 $25
Q1 2006 $28
Q4 2005 $34
Q3 2005 $38
Q2 2005 $1
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.103B $0.202B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.126B 27.02
Medtronic (MDT) Ireland $144.847B 20.33
Stryker (SYK) United States $74.230B 24.96
Boston Scientific (BSX) United States $55.990B 26.43
Baxter (BAX) United States $40.262B 24.42
EssilorLuxottica Societe Anonyme (ESLOY) France $32.646B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.479B 18.49
Terumo (TRUMY) Japan $26.826B 33.48
Lonza Group Ag (LZAGY) Switzerland $25.848B 0.00
Coloplast (CLPBY) Denmark $24.710B 39.45
ResMed (RMD) United States $20.688B 38.16
Smith & Nephew SNATS (SNN) United Kingdom $18.505B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.756B 511.73
Bio-Rad Laboratories (BIO) United States $10.475B 50.28
Canopy Growth (CGC) Canada $7.071B 0.00
Hill-Rom Holdings (HRC) United States $6.970B 20.53
Perrigo (PRGO) Ireland $6.683B 12.46
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.015B 40.64
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.751B 29.54
Aurora Cannabis (ACB) Canada $3.724B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.498B 0.00
ICU Medical (ICUI) United States $3.474B 22.66
Neogen (NEOG) United States $3.331B 55.74
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.989B 0.00
Quidel (QDEL) United States $2.472B 23.46
National Vision Holdings (EYE) United States $2.103B 47.83
Agios Pharmaceuticals (AGIO) United States $1.910B 0.00
Cardiovascular Systems (CSII) United States $1.587B 0.00
InMode (INMD) Israel $1.452B 0.00
VAREX IMAGING (VREX) United States $1.251B 28.84
Aphria (APHA) $1.250B 0.00
Phibro Animal Health (PAHC) United States $0.926B 17.34
Lantheus Holdings (LNTH) United States $0.845B 21.11
Eagle Pharmaceuticals (EGRX) United States $0.845B 21.54
NanoString Technologies (NSTG) United States $0.829B 0.00
TG Therapeutics (TGTX) United States $0.739B 0.00
Omeros (OMER) United States $0.677B 0.00
LeMaitre Vascular (LMAT) United States $0.660B 37.35
PetIQ (PETQ) United States $0.641B 15.68
Cerus (CERS) United States $0.574B 0.00
Quanterix (QTRX) United States $0.563B 0.00
HEXO (HEXO) $0.545B 0.00
Organigram Holdings (OGI) Canada $0.529B 0.00
Surmodics (SRDX) United States $0.527B 55.04
OraSure Technologies (OSUR) United States $0.511B 30.67
Owens & Minor (OMI) United States $0.429B 15.88
MacroGenics (MGNX) United States $0.389B 0.00
Utah Medical Products (UTMD) United States $0.381B 27.58
BioLife Solutions (BLFS) United States $0.340B 104.56
Meridian Bioscience (VIVO) United States $0.340B 11.69
Zynex (ZYXI) United States $0.295B 33.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 0.00
Bovie Medical (APYX) United States $0.245B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Repro-Med Systems (KRMD) United States $0.183B 0.00
Vapotherm (VAPO) United States $0.169B 0.00
InfuSystems Holdings (INFU) United States $0.143B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Fonar (FONR) United States $0.134B 9.40
Female Health (VERU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chimerix (CMRX) United States $0.103B 0.00
United-Guardian (UG) United States $0.089B 22.43
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
MTech Acquisition (KERN) United States $0.045B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00